Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Signal Transduction Signaling Pathway G Protein Signaling GPCR

Recombinant Human Frizzled 5 protein (Fc Chimera) (ab219684)

Recombinant Human Frizzled 5 protein (Fc Chimera) (ab219684)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Expression system: HEK 293 cells
  • Purity: > 95% SDS-PAGE
  • Endotoxin level:
  • Suitable for: SDS-PAGE

You may also be interested in

Product image
Anti-Motilin antibody (ab247173)
Product image
Anti-F2RL3 antibody - N-terminal (ab188930)
Product image
Anti-GPCR RDC1/CXCR-7 antibody (ab38089)
Product image
Anti-GPCR TGR5 antibody (ab72608)

Preparation and Storage

  • C2orf31
  • DKFZP434E2135
  • Frizzled 5 seven transmembrane spanning receptor

Images

  • SDS-PAGE - Recombinant Human Frizzled 5 protein (Fc Chimera) (ab219684)
    SDS-PAGE - Recombinant Human Frizzled 5 protein (Fc Chimera) (ab219684)

    SDS-PAGE analysis of DTT-reduced ab219684 stained overnight with Coomassie Blue.

    DTT-reduced protein migrates as 55-60 kDa in SDS-PAGE due to glycosylation.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.